CDE Detailed Report
Disease: general-data-protection-regulation-gdpr
Sub-Domain: Protocol Experience
CRF:

84 results.
CDE ID CDE Name Variable Name Definition Short Description Additional Notes (Question Text) Permissible Values Description Data Type Disease Specific Instructions Disease Specific Reference Population Classification (e.g., Core) Version Number Version Date CRF Name (CRF Module / Guideline) Sub Domain Name Domain Name Size Input Restrictions Min Value Max Value Measurement Type Source Form Set Form Field Domain CDASH Variable CDASH Definition CDASH Label Controlled Terminology Prompt Essentiality Question Text CDASH imp guidance SDTM IG target csDSR PhenX Data Type CRF Completion Inst SDTMIG Target Var SDTMIG Target Map Codelist Name PVs Pre Pop Value Query Display List Style
C58707 Focal neurological event abnormal T2 FLAIR acute infarct most recent date FocNeuevAbnT2FLRAcInMsRcDate Date of the subject/participant's most recent focal neurological event with abnormalities indicative of acute infarct on T2-weighted or FLAIR images. Date of the subject/participant's most recent focal neurological event with abnormalities indicative of acute infarct on T2-weighted or FLAIR images. Date of most recent focal neurological event resulting in abnormalities on T2-weighted or FLAIR images using an MRI scan Date or Date & Time Adult;Pediatric Proposed 1.00 2018-11-21 10:18:17.0 Haplo Sickle Cell Enrollment Form: Segment A Protocol Experience Participant/Subject Identification, Eligibility, and Enrollment

Free-Form Entry

BMTCTN 1507A Release 5.10 1507A (ENR) HSCSTRDT
C58739 Creatinine clearance sample date CreatininClearanceSampleDate Date on which the sample for creatinine clearance measurement was taken from the subject/participant. Date on which the sample for creatinine clearance measurement was taken from the subject/participant. Date creatinine clearance sample obtained Date or Date & Time Adult;Pediatric Proposed 1.00 2018-12-06 12:12:19.0 Haplo Sickle Cell Enrollment Form: Segment A Protocol Experience Participant/Subject Identification, Eligibility, and Enrollment

Free-Form Entry

BMTCTN 1507A Release 5.10 1507A (ENR) HSCCRDT
C58718 Pain crisis 2 year prior enrollment start date PnCris2YrPriorEnrolStartDate Start date of the severe vaso-occlusive pain crisis or painful episode related to priapism, osteonecrosis, or sickle-related complication two years prior to enrollment. Start date of the severe vaso-occlusive pain crisis or painful episode related to priapism, osteonecrosis, or sickle-related complication two years prior to enrollment. Start date of severe pain crisis 2 years prior to enrollment Date or Date & Time Adult;Pediatric Proposed 1.00 2018-12-06 10:12:39.0 Haplo Sickle Cell Enrollment Form: Segment A Protocol Experience Participant/Subject Identification, Eligibility, and Enrollment

Free-Form Entry

BMTCTN 1507A Release 5.10 1507A (ENR) HSC2P1DT
C58751 Liver MRI hepatic iron content valid methodology indicate code LivrMRIHepatcIrnCntntIndCode Code indicating whether a liver MRI (magnetic resonance imaging) was performed using a validated methodology for estimation of hepatic iron content. Code indicating whether a liver MRI (magnetic resonance imaging) was performed using a validated methodology for estimation of hepatic iron content. Was a liver MRI performed using a validated methodology per institutional preference (T2* or R2* or by ferriscan [R2 MRI]) for estimation of hepatic iron content? 1;2;1;2 Yes;No;Yes;No Numeric Values Adult;Pediatric Proposed 1.00 2018-12-10 12:35:20.0 Haplo Sickle Cell Enrollment Form: Segment A Protocol Experience Participant/Subject Identification, Eligibility, and Enrollment

Single Pre-Defined Value Selected

BMTCTN 1507A Release 5.10 1507A (ENR) HSCLMRI
C10179 Diffusion Capacity Corrected measurement DiffusionCapacityCorrectdMeasr Diffusion Capacity Corrected (DLCO CORR) = A correction for predicted value is made using patients Hemoglobin Diffusion Capacity Corrected (DLCO CORR) = A correction for predicted value is made using patients Hemoglobin Record patient's DLCO value (corrected for hemoglobin) Numeric Values Adult;Pediatric Proposed 3.00 2013-07-22 09:34:41.527 Haplo Sickle Cell Enrollment Form: Segment A Protocol Experience Participant/Subject Identification, Eligibility, and Enrollment

Free-Form Entry

C58729 Performance status result code PerformanceStatusResultCode Code for the result of the subject/participant's performance status using the Karnofsky or Lansky performance status scale. Code for the result of the subject/participant's performance status using the Karnofsky or Lansky performance status scale. Record patient's performance status 02;03;04;05;06;07;08;09;10;01 90 (Normal Activity/Minor Restriction in Strenuous Play);80 (Normal Activity with Effort/Restricted in Strenuous Play);70 (Unable to Carry On Normal Activity/Less Time Spent in Play);60 (Requires Occasional Assistance/Minimal Active Play);50 (Requires Considerable Assistance/No Active Play);40 (Disabled/Able to Initiate Quiet Activities);30 (Severely Disabled/Needs Assistance for Quiet Play);20 (Very Sick/Limited to Very Passive Activity);10 (Moribund, Completely Disabled);100 (Normal, No Complaints/Fully Active) Numeric Values Adult;Pediatric Proposed 1.00 2018-12-06 11:24:22.0 Haplo Sickle Cell Enrollment Form: Segment A Protocol Experience Participant/Subject Identification, Eligibility, and Enrollment

Single Pre-Defined Value Selected

BMTCTN 1507A Release 5.10 1507A (ENR) HSCPSR
C58772 Hematopoietic stem cell transplant previous indicate code HTCPrevIndCode Code indicating whether the subject/participant has received a previous hematopoietic stem cell transplant (HCT). Code indicating whether the subject/participant has received a previous hematopoietic stem cell transplant (HCT). Has the patient received a previous hematopoietic stem cell transplant (HCT)? 1;2;1;2 Yes;No;Yes;No Numeric Values Adult;Pediatric Proposed 1.00 2018-12-10 16:13:44.0 Haplo Sickle Cell Enrollment Form: Segment A Protocol Experience Participant/Subject Identification, Eligibility, and Enrollment

Single Pre-Defined Value Selected

BMTCTN 1507A Release 5.10 1507A (ENR) HSCHCT
C58789 Protocol chair officer approve date ProtocolChairOfficerAproveDate Date on which the Protocol Chair and/or Protocol Officer approved a variance from study protocol. Date on which the Protocol Chair and/or Protocol Officer approved a variance from study protocol. Date of Protocol Chair and/or Protocol Officer approval Date or Date & Time Adult;Pediatric Proposed 1.00 2018-12-11 12:15:49.0 Haplo Sickle Cell Enrollment Form: Segment A Protocol Experience Participant/Subject Identification, Eligibility, and Enrollment

Free-Form Entry

BMTCTN 1507A Release 5.10 1507A (ENR) HSCAPDT
C58708 Clincal radiologic evidence cerebral infarct 30 day prior enrollment indicate code ClnRadEvCerInf30DyPrEnrIndCode Code indicating whether there was clinical or radiological evidence of a recent cerebral infarct by cerebral MRI/MRA within 30 days prior to enrollment. Code indicating whether there was clinical or radiological evidence of a recent cerebral infarct by cerebral MRI/MRA within 30 days prior to enrollment. Was there clinical or radiologic evidence of a recent cerebral infarct by cerebral MRI/MRA within 30 days prior to enrollment? 1;2;1;2 Yes;No;Yes;No Numeric Values Adult;Pediatric Proposed 1.00 2018-11-21 12:35:08.0 Haplo Sickle Cell Enrollment Form: Segment A Protocol Experience Participant/Subject Identification, Eligibility, and Enrollment

Single Pre-Defined Value Selected

BMTCTN 1507A Release 5.10 1507A (ENR) HSCRECNE
C58740 Hyperbilirubinemia indicate code HyperbilirubinemiaIndCode Code indicating whether the subject/participant has hyperbilirubinemia Code indicating whether the subject/participant has hyperbilirubinemia Does the patient have hyperbilirubinemia? 1;2;1;2 Yes;No;Yes;No Numeric Values Adult;Pediatric Proposed 1.00 2018-12-06 12:14:07.0 Haplo Sickle Cell Enrollment Form: Segment A Protocol Experience Participant/Subject Identification, Eligibility, and Enrollment

Single Pre-Defined Value Selected

BMTCTN 1507A Release 5.10 1507A (ENR) HSCHYPER
C58719 Pain crisis 1 year prior enrollment start date PnCris1YrPriorEnrolStartDate Start date of the severe vaso-occlusive pain crisis or painful episode related to priapism, osteonecrosis, or sickle-related complication one year prior to enrollment. Start date of the severe vaso-occlusive pain crisis or painful episode related to priapism, osteonecrosis, or sickle-related complication one year prior to enrollment. Start date of severe pain crisis 1 year prior to enrollment Date or Date & Time Adult;Pediatric Proposed 1.00 2018-12-06 10:12:39.0 Haplo Sickle Cell Enrollment Form: Segment A Protocol Experience Participant/Subject Identification, Eligibility, and Enrollment

Free-Form Entry

BMTCTN 1507A Release 5.10 1507A (ENR) HSC1P1DT
C58752 Liver MRI date LiverMRIDate Date on which liver MRI (magnetic resonance imaging) was performed. Date on which liver MRI (magnetic resonance imaging) was performed. Record date of liver MRI Date or Date & Time Adult;Pediatric Proposed 1.00 2018-12-10 12:42:35.0 Haplo Sickle Cell Enrollment Form: Segment A Protocol Experience Participant/Subject Identification, Eligibility, and Enrollment

Free-Form Entry

BMTCTN 1507A Release 5.10 1507A (ENR) HSCLMRDT
C58775 Transplant solid organ ever receive indicate code TrpltSldOrgnEverRcvIndCode Code indicating whether the subject/participant has ever received a solid organ transplant. Code indicating whether the subject/participant has ever received a solid organ transplant. Has the patient received a prior solid organ transplant? 1;2;1;2 Yes;No;Yes;No Numeric Values Adult;Pediatric Proposed 1.00 2018-12-11 09:45:45.0 Haplo Sickle Cell Enrollment Form: Segment A Protocol Experience Participant/Subject Identification, Eligibility, and Enrollment

Single Pre-Defined Value Selected

BMTCTN 1507A Release 5.10 1507A (ENR) HSCORTXP
C10724 Echocardiogram performed date and time EchcrdgrmPerfrmDateTime Date (and time, if applicable and known) the echocardiography was performed Date (and time, if applicable and known) the echocardiography was performed Date echocardiograph was performed Date or Date & Time Adult;Pediatric Proposed 3.00 2013-07-25 08:54:08.2 Haplo Sickle Cell Enrollment Form: Segment A Protocol Experience Participant/Subject Identification, Eligibility, and Enrollment

Free-Form Entry

C58730 Cardiac fraction test type code CardiacFractionTestTypeCode Code for the type of cardiac fraction test performed. Code for the type of cardiac fraction test performed. Record the type of cardiac fraction test performed 1;2 Left Ventricular Ejection Fraction (LVEF);Shortening Fraction Numeric Values Adult;Pediatric Proposed 1.00 2018-12-06 11:37:18.0 Haplo Sickle Cell Enrollment Form: Segment A Protocol Experience Participant/Subject Identification, Eligibility, and Enrollment

Single Pre-Defined Value Selected

BMTCTN 1507A Release 5.10 1507A (ENR) HSCCFT
C58790 Donor bone marrow willing indicate code DonrBoneMarwWillIndCode Code indicating whether the donor is willing to donate bone marrow. Code indicating whether the donor is willing to donate bone marrow. Is the donor willing to donate bone marrow? 1;2;1;2 Yes;No;Yes;No Numeric Values Adult;Pediatric Proposed 1.00 2018-12-11 13:00:20.0 Haplo Sickle Cell Enrollment Form: Segment A Protocol Experience Participant/Subject Identification, Eligibility, and Enrollment

Single Pre-Defined Value Selected

BMTCTN 1507A Release 5.10 1507A (ENR) HSCDWILL
C58709 Defer 6 month due clinical radiologic evidence cerebral infarct 30 day prior enrollment indicate code Df6MoDuClRaEvCeIn30DyPrEnInCod Code indicating whether the subject/participant's enrollment was deferred for at least 6 months due to clinical or radiological evidence of a recent cerebral infarct by cerebral MRI/MRA within 30 days prior to enrollment. Code indicating whether the subject/participant's enrollment was deferred for at least 6 months due to clinical or radiological evidence of a recent cerebral infarct by cerebral MRI/MRA within 30 days prior to enrollment. Was the patient previously deferred for >= 6 months due to clinical or radiologic evidence of a recent cerebral infarct by cerebral MRI/MRA within 30 days prior to enrollment? 1;2;1;2 Yes;No;Yes;No Numeric Values Adult;Pediatric Proposed 1.00 2018-11-21 12:35:08.0 Haplo Sickle Cell Enrollment Form: Segment A Protocol Experience Participant/Subject Identification, Eligibility, and Enrollment

Single Pre-Defined Value Selected

BMTCTN 1507A Release 5.10 1507A (ENR) HSCDEFER
C58741 Hyperbilirubinemia reason hyperhemolysis post transfusion hemoglobin drop indicate code HypbilrRsnHyphemPoTrHbDpIndCod Code indicating whether the subject/participant's hyperbilirubinemia is a result of hyperhemolysis or of a severe drop in hemoglobin following blood transfusion. Code indicating whether the subject/participant's hyperbilirubinemia is a result of hyperhemolysis or of a severe drop in hemoglobin following blood transfusion. Is the patient's hyperbilirubinemia a result of hyperhemolysis or a severe drop in hemoglobin post blood transfusion? 1;2;1;2 Yes;No;Yes;No Numeric Values Adult;Pediatric Proposed 1.00 2018-12-06 12:16:18.0 Haplo Sickle Cell Enrollment Form: Segment A Protocol Experience Participant/Subject Identification, Eligibility, and Enrollment

Single Pre-Defined Value Selected

BMTCTN 1507A Release 5.10 1507A (ENR) HSCHYPHE
C58720 Pain crisis information not available specify text PnCrisInfoNotAvailSpecifyTxt Text field for specifying why information about the severe vaso-occlusive pain crisis or painful episode related to priapism, osteonecrosis, or sickle-related complication was not available. Text field for specifying why information about the severe vaso-occlusive pain crisis or painful episode related to priapism, osteonecrosis, or sickle-related complication was not available. Specify why pain crises information was not available Alphanumeric Adult;Pediatric Proposed 1.00 2018-12-06 10:18:08.0 Haplo Sickle Cell Enrollment Form: Segment A Protocol Experience Participant/Subject Identification, Eligibility, and Enrollment 255

Free-Form Entry

BMTCTN 1507A Release 5.10 1507A (ENR) HSCPCSP
C58753 Iron overload significant clinical evidence indicate code IronOverloadSigClinEvdncIndCod Code indicating whether the subject/participant has significant clinical evidence of iron overload. Code indicating whether the subject/participant has significant clinical evidence of iron overload. Does the patient have significant clinical evidence of iron overload (estimated hepatic iron content >= 10mg Fe/g liver dry weight)? 1;2;1;2 Yes;No;Yes;No Numeric Values Adult;Pediatric Proposed 1.00 2018-12-10 12:44:53.0 Haplo Sickle Cell Enrollment Form: Segment A Protocol Experience Participant/Subject Identification, Eligibility, and Enrollment

Single Pre-Defined Value Selected

BMTCTN 1507A Release 5.10 1507A (ENR) HSCFEOV
C58776 Other clinical trial drug device investigational off-label past 3 month indicate code OtClTrDrDvInOfLbPs3MoIndCode Code indicating whether in the past 3 months the subject/participant participated in another clinical trial of an investigational or off-label use of a drug or device. Code indicating whether in the past 3 months the subject/participant participated in another clinical trial of an investigational or off-label use of a drug or device. Has the patient participated in another clinical trial in which the patient received an investigational or off-label use of a drug or device within 3 months of enrollment? 1;2;1;2 Yes;No;Yes;No Numeric Values Adult;Pediatric Proposed 1.00 2018-12-11 09:49:49.0 Haplo Sickle Cell Enrollment Form: Segment A Protocol Experience Participant/Subject Identification, Eligibility, and Enrollment

Single Pre-Defined Value Selected

BMTCTN 1507A Release 5.10 1507A (ENR) HSCCLTR
C10740 Echocardiogram left ventricle ejection fraction measurement EchcrdLftVentEjctnFractnMeasr Fraction of blood pumped out of the left ventricles with each heart beat measured with echocardiography Fraction of blood pumped out of the left ventricles with each heart beat measured with echocardiography Left ventricular ejection fraction Numeric Values Adult;Pediatric Proposed 3.00 2013-07-24 11:38:01.2 Haplo Sickle Cell Enrollment Form: Segment A Protocol Experience Participant/Subject Identification, Eligibility, and Enrollment

Free-Form Entry

percent
C58731 Left ventricular ejection fraction perform date LVEFPerformDate Date on which the left ventricular ejection fraction (LVEF) test was performed Date on which the left ventricular ejection fraction (LVEF) test was performed Date LV ejection fraction performed Date or Date & Time Adult;Pediatric Proposed 1.00 2018-12-06 11:41:18.0 Haplo Sickle Cell Enrollment Form: Segment A Protocol Experience Participant/Subject Identification, Eligibility, and Enrollment

Free-Form Entry

BMTCTN 1507A Release 5.10 1507A (ENR) HSCLVEDT
C58791 Donor meet institution protocol criteria indicate code DonrMeetInstProtCritIndCode Code indicating whether the donor meets institutional and protocol criteria for donation Code indicating whether the donor meets institutional and protocol criteria for donation Does the donor meet institutional and protocol-specified criteria for donation? 1;2;1;2 Yes;No;Yes;No Numeric Values Adult;Pediatric Proposed 1.00 2018-12-11 13:02:29.0 Haplo Sickle Cell Enrollment Form: Segment A Protocol Experience Participant/Subject Identification, Eligibility, and Enrollment

Single Pre-Defined Value Selected

BMTCTN 1507A Release 5.10 1507A (ENR) HSCDCRIT
C58710 MRI MRA evidence cerebral infarct date MriMraEvidCerebInfrctDate Date of cerebral MRI/MRA with evidence of a cerebral infarct. Date of cerebral MRI/MRA with evidence of a cerebral infarct. Record the date of the cerebral MRI/MRA with evidence of a cerebral infarct Date or Date & Time Adult;Pediatric Proposed 1.00 2018-11-21 12:47:10.0 Haplo Sickle Cell Enrollment Form: Segment A Protocol Experience Participant/Subject Identification, Eligibility, and Enrollment

Free-Form Entry

BMTCTN 1507A Release 5.10 1507A (ENR) HSCMRIDT
C58742 Bilirubin most recent direct measurement BlrubinMstRcntDrctMeasr Measurement in milligrams per deciliter for the most recent direct measurement of bilirubin. Measurement in milligrams per deciliter for the most recent direct measurement of bilirubin. Direct bilirubin most recent value (mg/dL) Numeric Values Adult;Pediatric Proposed 1.00 2018-12-07 13:01:37.0 Haplo Sickle Cell Enrollment Form: Segment A Protocol Experience Participant/Subject Identification, Eligibility, and Enrollment

Free-Form Entry

0 9.9 milligram per deciliter BMTCTN 1507A Release 5.10 1507A (ENR) HSCBILI
C58721 Red blood cell transfusion multiple per year 12 month prior enrollment indicate code RBCTrfnMltPrYr12MoPriEnrIndCod Code indicating whether the subject/participant has received multiple packed red blood cell (RBC) transfusions per year for at least one year during the 12 months prior to enrollment. Code indicating whether the subject/participant has received multiple packed red blood cell (RBC) transfusions per year for at least one year during the 12 months prior to enrollment. Has the patient received >= 8 packed red blood cell (RBC) transfusions per year for >= 1 year in the 12 months before enrollment to prevent vaso-occlusive clinical complications (i.e. pain, stroke, and acute chest syndrome)? 1;2;3 Yes;No;Unavailable Numeric Values Adult;Pediatric Proposed 1.00 2018-12-06 10:26:21.0 Haplo Sickle Cell Enrollment Form: Segment A Protocol Experience Participant/Subject Identification, Eligibility, and Enrollment

Single Pre-Defined Value Selected

BMTCTN 1507A Release 5.10 1507A (ENR) HSCRBC
C58754 Liver biopsy performed indicate code LiverBiopsyPerformIndicateCode Code indicating whether a liver biopsy was performed. Code indicating whether a liver biopsy was performed. Was a liver biopsy performed? 1;2;1;2 Yes;No;Yes;No Numeric Values Adult;Pediatric Proposed 1.00 2018-12-10 12:48:47.0 Haplo Sickle Cell Enrollment Form: Segment A Protocol Experience Participant/Subject Identification, Eligibility, and Enrollment

Single Pre-Defined Value Selected

BMTCTN 1507A Release 5.10 1507A (ENR) HSCLIVBX
C58777 Pregnant breastfeed current indicate code PregBreastfeetCurrentIndCode Code indicating whether the subject/participant is currently pregnant or breastfeeding. Code indicating whether the subject/participant is currently pregnant or breastfeeding. Is the patient pregnant or breastfeeding? 1;2;3 Yes;No;Not Applicable Numeric Values Adult;Pediatric Proposed 1.00 2018-12-11 09:56:06.0 Haplo Sickle Cell Enrollment Form: Segment A Protocol Experience Participant/Subject Identification, Eligibility, and Enrollment

Single Pre-Defined Value Selected

BMTCTN 1507A Release 5.10 1507A (ENR) HSCPREG
C10744 Echocardiogram left ventricle fractional shortening measurement EchcrdgrmLftVentFractShrtMeasr Measurement of the difference between end-diastolic and end-systolic dimensions of the left ventricle divided by end-diastolic dimension assessed with echocardiography. FS or Fractional Shortening in percentage = EDD minus ESD divided by EDD times 100, where EDD = LV End Diastolic Dimension and ESD = LV End Systolic Dimension. Measurement of the difference between end-diastolic and end-systolic dimensions of the left ventricle divided by end-diastolic dimension assessed with echocardiography. LV Shortening fraction Numeric Values Adult;Pediatric Proposed 3.00 2013-07-24 11:38:01.2 Haplo Sickle Cell Enrollment Form: Segment A Protocol Experience Participant/Subject Identification, Eligibility, and Enrollment

Free-Form Entry

percent
C58732 Left ventricular shortening fraction perform date LftVentShortFracPerfDate Date on which the left ventricular shortening fraction test was performed. Date on which the left ventricular shortening fraction test was performed. Date LV shortening fraction performed Date or Date & Time Adult;Pediatric Proposed 1.00 2018-12-06 11:43:47.0 Haplo Sickle Cell Enrollment Form: Segment A Protocol Experience Participant/Subject Identification, Eligibility, and Enrollment

Free-Form Entry

BMTCTN 1507A Release 5.10 1507A (ENR) HSCSFDT
C58792 Donor have clinically significant hemoglobinopathy indicate code DonrHavClinSigHmglobpthIndCode Code indicating whether the donor has a clinically significant hemoglobinopathy. Code indicating whether the donor has a clinically significant hemoglobinopathy. Does the donor have a clinically significant hemoglobinopathy? 1;2;1;2 Yes;No;Yes;No Numeric Values Adult;Pediatric Proposed 1.00 2018-12-11 13:36:00.0 Haplo Sickle Cell Enrollment Form: Segment A Protocol Experience Participant/Subject Identification, Eligibility, and Enrollment

Single Pre-Defined Value Selected

BMTCTN 1507A Release 5.10 1507A (ENR) HSCHEM
C58711 MRI MRA evidence cerebral infarct stabilization repeat date MriMraEviCerInfStabRptDate Date on which a repeat MRI/MRA was performed which provided evidence of stabilization of the cerebral infarct. Date on which a repeat MRI/MRA was performed which provided evidence of stabilization of the cerebral infarct. Record the date of the repeat cerebral MRI/MRA with evidence of stabilization of the cerebral infarct Date or Date & Time Adult;Pediatric Proposed 1.00 2018-11-21 12:49:43.0 Haplo Sickle Cell Enrollment Form: Segment A Protocol Experience Participant/Subject Identification, Eligibility, and Enrollment

Free-Form Entry

BMTCTN 1507A Release 5.10 1507A (ENR) HSCRMRDT
C58743 Direct bilirubin institutional upper limit normal age value DirBlrbnInstULNAgeVal Value of the institutional upper limit of normal (ULN) for the subject/participant's age for bilirubin measured directly. Value of the institutional upper limit of normal (ULN) for the subject/participant's age for bilirubin measured directly. Institutional ULN of direct bilirubin for age Numeric Values Adult;Pediatric Proposed 1.00 2018-12-07 00:00:00.0 Haplo Sickle Cell Enrollment Form: Segment A Protocol Experience Participant/Subject Identification, Eligibility, and Enrollment

Free-Form Entry

0 9.9 milligram per deciliter BMTCTN 1507A Release 5.10 1507A (ENR) HSCBILIU
84 results.
CSV